About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Lancet Diabetes and Endocrinology,the
›
Top Articles
Lancet Diabetes and Endocrinology,the
Endocrinology
18.1
(top 1%)
Impact Factor
19.5
(top 1%)
extended IF
145
(top 2%)
H-Index
1.9K
authors
1.7K
papers
74.3K
citations
5.1K
citing journals
51.6K
citing authors
Most Cited Articles of Lancet Diabetes and Endocrinology,the
Title
Year
Citations
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
2018
810
Vitamin D status and ill health: a systematic review
2014
732
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
634
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
2015
585
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2019
522
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
2015
501
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases
2014
486
Diabetes: a 21st century challenge
2014
472
Practical recommendations for the management of diabetes in patients with COVID-19
2020
463
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment
2014
446
Preconceptional and maternal obesity: epidemiology and health consequences
2016
429
Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial
2015
424
Influence of maternal obesity on the long-term health of offspring
2017
421
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
2017
419
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
2014
410
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
2013
409
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
2020
407
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
2020
406
Obesity, inflammation, and the gut microbiota
2015
405
Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses
2016
392
Exercise management in type 1 diabetes: a consensus statement
2017
391
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
2014
385
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
2015
381
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
2020
375
Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study
2017
372
previous
2017
2018
2019
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.